Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

ClinicalTrials.gov ID: NCT00257205

Public ClinicalTrials.gov record NCT00257205. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 3:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open Label, Randomized, Comparative Study Of CP-675,206 And Either Dacarbazine Or Temozolomide In Patients With Advanced Melanoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, multi-national, open-label, 2-arm randomized study in patients with surgically incurable metastatic melanoma who have received no prior chemotherapy, or biochemotherapy for the treatment of metastatic disease. The primary objective of this trial is to compare overall survival for patients with advanced melanoma who are randomized to receive CP-675,206 with that of patients who are randomized to receive either dacarbazine or temozolomide (investigator choice)

Study identification

NCT ID
NCT00257205
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
655 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2006 (Type not available)
Primary completion
Aug 2010 (Actual)
Completion
Aug 2010 (Actual)
Last update posted
Jul 2, 2012

2006 – 2010

United States locations

U.S. sites
55
U.S. states
21
U.S. cities
48
Facility City State ZIP Site status
Research Site Huntsville Alabama 35805 —
Research Site Mobile Alabama 36607 —
Research Site Scottsdale Arizona 85260 —
Research Site Little Rock Arkansas 72205 —
Research Site Bakersfield California 93309 —
Research Site Corona California 92879 —
Research Site Fullerton California 92835 —
Research Site Glendora California 91741 —
Research Site Huntington Beach California 92648 —
Research Site Long Beach California 90813 —
Research Site Los Alamitos California 90720 —
Research Site Los Angeles California 90095-6970 —
Research Site Los Angeles California 90095 —
Research Site Oxnard California 93030 —
Research Site Pasadena California 91105 —
Research Site Pomona California 91767 —
Research Site Rancho Cucamonga California 91730 —
Research Site Santa Barbara California 93105 —
Research Site Santa Maria California 93454 —
Research Site West Covina California 91790 —
Research Site Aurora Colorado 80045 —
Research Site Stamford Connecticut 06902-3628 —
Research Site Boynton Beach Florida 33426 —
Research Site Lake Worth Florida 33461-4710 —
Research Site Zion Illinois 60099 —
Research Site Beech Grove Indiana 46107 —
Research Site Indianapolis Indiana 46237 —
Research Site Indianapolis Indiana 46260 —
Research Site Baltimore Maryland 21237-3998 —
Research Site City of Saint Peters Missouri 63376 —
Research Site Creve Coeur Missouri 63141 —
Research Site St Louis Missouri 63110 —
Research Site Omaha Nebraska 68114 —
Research Site Henderson Nevada 89015 —
Research Site Henderson Nevada 89052 —
Research Site Las Vegas Nevada 89109 —
Research Site Las Vegas Nevada 89128 —
Research Site Las Vegas Nevada 89135 —
Research Site Las Vegas Nevada 89148 —
Research Site Morristown New Jersey 07962 —
Research Site Albany New York 12206 —
Research Site New York New York 10016 —
Research Site Chapel Hill North Carolina 27599-7600 —
Research Site Charlotte North Carolina 28203 —
Research Site Charlotte North Carolina 28204 —
Research Site Canton Ohio 44718 —
Research Site Columbus Ohio 43210 —
Research Site Dover Ohio 44718 —
Research Site Bethlehem Pennsylvania 18015 —
Research Site Pittsburgh Pennsylvania 15232 —
Research Site Dallas Texas 75246 —
Research Site Salt Lake City Utah 84112 —
Research Site Federal Way Washington 98003 —
Research Site Lakewood Washington 98499 —
Research Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 88 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00257205, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2012 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00257205 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →